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Abstract
Background: Transmembrane proteins (TM proteins) make up 25% of all proteins and play key roles in many
diseases and normal physiological processes. However, much less is known about their structures and molecular
mechanisms than for soluble proteins. Problems in expression, solubilization, purification, and crystallization cause
bottlenecks in the characterization of TM proteins. This project addressed the need for improved methods for
obtaining sufficient amounts of TM proteins for determining their structures and molecular mechanisms.
Results: Plasmid clones were obtained that encode eighty-seven transmembrane proteins with varying physical
characteristics, for example, the number of predicted transmembrane helices, molecular weight, and grand average
hydrophobicity (GRAVY). All the target proteins were from P. aeruginosa, a gram negative bacterial opportunistic
pathogen that causes serious lung infections in people with cystic fibrosis. The relative expression levels of the
transmembrane proteins were measured under several culture growth conditions. The use of E. coli strains, a T7
promoter, and a 6-histidine C-terminal affinity tag resulted in the expression of 61 out of 87 test proteins (70%). In
this study, proteins with a higher grand average hydrophobicity and more transmembrane helices were expressed
less well than less hydrophobic proteins with fewer transmembrane helices.
Conclusions: In this study, factors related to overall hydrophobicity and the number of predicted transmembrane
helices correlated with the relative expression levels of the target proteins. Identifying physical characteristics that
correlate with protein expression might aid in selecting the “low hanging fruit”, or proteins that can be expressed
to sufficient levels using an E. coli expression system. The use of other expression strategies or host species might
be needed for sufficient levels of expression of transmembrane proteins with other physical characteristics. Surveys
like this one could aid in overcoming the technical bottlenecks in working with TM proteins and could potentially
aid in increasing the rate of structure determination.
Background
Ion transport, cell-cell communication, vesicle transport,
maintenance of cellular structure, drug resistance, host-
pathogen interactions and many other vital cellular
activities involve proteins that are embedded in the cell
membrane. Transmembrane [TM] proteins make up
over 25% of an organism’s proteins [1-3] and are the
targets for the majority of pharmaceuticals in use today
[4]. The improper folding or activity of TM proteins
lead to important genetic diseases, including cystic
fibrosis and diabetes. The variety of roles of transmem-
brane proteins in physiological functions important to
both medicine and basic science make the determination
of transmembrane protein structures and molecular
mechanisms an important goal, but, in spite of their
vast importance, there are far fewer structures and
molecular mechanisms known for TM proteins than for
soluble proteins. While there are almost two hundred
structures of alpha-helical membrane proteins in the
PDB, problems in transmembrane protein expression,
solubilization, and structure determination have led
many researchers instead to focus on soluble proteins.
Currently, the majority of structural genomic projects
focus on the soluble proteins, the “low-hanging fruit”,
due to their relative ease of expression, purification, and
crystallization.
One of the key bottlenecks in studying transmembrane
proteins has been expression of sufficient amounts of
protein for biochemical and structural characterization.
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For many soluble proteins and some transmembrane
proteins, recombinant expression in E. coli provides a
sufficient amount of protein for many types of studies
and has the advantages of ease of use, low cost, and abil-
ity to be scaled up. Some transmembrane proteins can be
expressed in E. coli at sufficient levels for biochemical
studies, but it is not clear which ones. Transmembrane
proteins vary in the number of transmembrane helices
(Figure 1), size, overall hydrophobicity, size of domains
outside the membrane, and other physical features that
might play a role in determining if a transmembrane pro-
tein will be expressed at high levels in E. coli. Identifying
those physical features that affect recombinant expres-
sion levels could facilitate the identification of proteins
that could be expressed at sufficient levels for biochem-
ical and structural studies.
We have performed a systematic study of recombinant
expression of transmembrane proteins in E. coli. We
have selected a medically important gram-negative bac-
terium, Pseudomonas aeruginosa, as the source of the
proteins. Using proteins from a bacterium avoids many
of the potential complications that might affect expres-
sion of human or other mammalian proteins such as lack
of glycosylation or other post-translational modifications.
Pseudomonas aeruginosa is an opportunistic bacterial
pathogen that infects burn patients, immunocompro-
mised patients, and cystic fibrosis patients. Cystic fibrosis
is the most common lethal genetic disease in North
America. Chronic lung infections by P. aeruginosa and
the inflammatory host immune response are major
causes of the progressive lung damage and low life expec-
tancy of CF patients. P. aeruginosa is also a common
cause of nosocomially-acquired infections due to its
intrinsic resistance to many drugs. Better methods to era-
dicate P. aeruginosa infections are needed to help
decrease lung damage in CF patients and increase the life
span of CF, burn, immunocompromised, and other
patients. Of particular interest are the numerous trans-
membrane proteins involved in antibiotic resistance and
efflux, pathogen-host interactions, cell-cell signaling,
quorum sensing, and other steps in infection and viru-
lence. In addition to specific proteins involved in these
processes, P. aeruginosa provides many other important
transmembrane protein targets for studying activities like
transport and signaling, as well as for studying trans-
membrane protein structure and folding.
We tested the recombinant expression of eighty-seven
transmembrane proteins from P. aeruginosa with a vari-
ety of physical features and functions to determine if
those factors play a role in relative expression level. We
also evaluated several culture growth conditions in order
to assess which provided superior protein expression.
Results and Discussion
Selection of Proteins
The vast majority of transmembrane proteins are pre-
dicted to have membrane-embedded regions composed of
alpha-helices [reviewed in [5-7]]. Exceptions include pro-
teins in the outer membrane of gram-negative bacteria,
mitochondria and chloroplasts and some toxins. For this
study, we are focusing on transmembrane proteins for
which the membrane-embedded domain is predicted to be
made up of transmembrane helices. Hydropathy analysis
indicates that Pseudomonas aeruginosa encodes 1334 pro-
teins that are predicted to have at least 1 transmembrane
helix (out of 5568 predicted genes in the genome), how-
ever, a single predicted transmembrane helix might be a
cleaved signal sequence, so only those proteins with two
or more predicted TM regions were included, of which
there are 930. Target proteins were selected based on sev-
eral physical features and to include proteins with a variety
of functions. Most proteins annotated as a “subunit” were
not selected for the study because attempts to express a
subunit of a larger multimer might not result in correctly
folded and stable protein. Our selection strategy provides
target proteins with a variety of physical characteristics
and functions for the expression tests. It should be noted
that correlation of individual characteristics with protein
expression levels might not be simple and clear-cut. Sev-
eral factors are likely to contribute to the results, for
example the number of TM helices in combination with
the sizes interhelical loops. Because of this, a large number
of protein targets were selected and general trends were
studied.
Cloning Steps
Invitrogen’s Gateway system was chosen for cloning and
expressing many proteins in parallel, and has been used
by several groups for high-throughput protein expres-
sion [8,9]. Benefits for potential future projects using
Figure 1 Schematic diagram of TM protein topology. The
number of TM helices, the lengths of the N- and C-terminal
domains, and the sizes of the interhelical loops or domains vary.
Some TM proteins are located predominantly within the membrane
(D), but others have more extensive N- or C-termini and/or
cytoplasmic or periplasmic loops (A, B, C) that can form
independently folding globular domains.
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these plasmids include: [1] The Entry Clone enables
quick transfer the cloned gene of interest into additional
vectors, which can enable expression in different organ-
isms or can include features like different affinity tags.
(2) Bacterial cultures can be scaled up for selected pro-
teins, for future work on purification and biochemical
or structural characterization. (3) The 6-histidine (6-His)
affinity tag added for Western blot analysis can also be
used for purification of selected target proteins using
nickel chelating columns. (4) The plasmids can be used
for expression of selected target proteins in auxotroph
strains for incorporation of selenomethionine or seleno-
cysteine, respectively, to aid in structural determination
by MAD phasing [10]. We obtained through cloning
and from the Harvard Proteomics lab and Open Biosys-
tems a total of 87 plasmids for our study. The proteins
studied are listed in Additional file 1.
Expression
Protein expression was tested in two strains and up to
four different temperatures (Table 1). E. coli BL21-AI is a
commonly used expression strain that is a derivative of
BL21(DE3). CD43(DE3) is also a derivative of BL21(DE3)
and was reported to overproduce TM proteins with less
toxicity [11]. The expression experiments were repeated
at multiple temperatures (37°C, 30°C, 20°C, and 12°C for
BL21-AI, and 37°C and 30°C for CD43(DE3)). Expression
at lower temperatures is expected to lower the translation
rate, which might slow down demands on the translocon
and also might provide the target proteins with an
increased chance of folding correctly. Overall, we
observed expression of 61 out of 87 target proteins, or
70%. It should be noted that, although we refer to our
studies as “expression studies”, a number of factors,
including rate of expression and stability of the protein,
contribute to the amount of protein observed: Some pro-
teins might not appear on the Western blots because
they are (a) unstable or (b) normally found in the cell as
part of a complex with other proteins (or a cofactor) and
aren’t properly folded or stable without concurrent
expression of other members of the complex or (c) nor-
mally interact with cytosolic or peripheral proteins that
are limited in these overexpressing conditions, or (d) are
toxic to the cell. Because we do not have all this informa-
tion for every target protein, we were unable to correct
for these kinds of nonexpressed proteins, but the large
number of target proteins in the study helped us look for
general trends.
It is interesting to note that of the twenty proteins that
were annotated as “hypothetical” or “unknown”, nine
were expressed and eleven were not (45% expressed).
This number is lower than the number that were
expressed of the proteins with a known function or with
a predicted or “probable” function based on sequence
similarity (78% expressed). One possibility is that pro-
teins that are difficult to express using recombinant DNA
methods are less likely to be characterized, and it is pos-
sible that their homologues from other species might also
be difficult to express using recombinant DNA methods.
Expression of the target proteins was monitored by Wes-
tern blotting using anti-6-His tag antibodies (Figure 2).
Other labs noted difficulties in the transfer of larger, more
hydrophobic membrane proteins to the blot [12], but we
did not observe this difficulty. The majority of lanes in the
Western blots had at least one additional band in addition
to the band running at the predicted molecular weight,
although these other bands were usually lighter than the
band at the predicted molecular weight. Using Western
blots with anti-6-His tag antibodies allowed us to estimate
the expression levels of the full-length proteins, ignore
these background or nonspecific bands, and at the same
time to check for protein size and potential degradation
products. Other methods, such as dot-blots, do not allow
for this assessment. It has previously been noted that mem-
brane transport proteins often migrate on SDS-PAGE gels
at only 65-75% of their true molecular weight, possibly due
to their hydrophobicity, binding of relatively large amounts
of SDS, or their retention of some alpha-helical secondary
structure enabling them to move more quickly through the
gel [13]. For most of the P. aeruginosa proteins in our
study, a band was observed at approximately the expected
molecular weight. In some cases, additional bands corre-
sponding to lower molecular weight species were detected,
suggesting that some proteolysis of the TM protein may
have occurred. For a few proteins, a smear was observed
running at higher molecular weight than the main band for
Table 1 Expression Results Based on Strain and Temperature
Strain Temperature Number of
Proteins Tested
Positive Expression Percent of Proteins
Expressed
BL21-AI 14 °C 85 32 38%
BL21-AI 20 °C 85 49 58%
BL21-AI 30 °C 85 48 56%
BL21-AI 37 °C 85 22 26%
C43(DE3) 30 °C 87 27 31%
C43(DE3) 37 °C 87 42 48%
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the protein, possibly due to nonspecific aggregation.
Thirty-eight of the 58 expressed proteins were expressed
with no smearing at any temperature in any strain, and 10
expressed proteins had smears in half of the conditions
tested. Because the majority of the proteins had smears in
more than one condition, it is likely that it is a characteris-
tic of the protein, not the preparation.
Proteins that were expressed tended to be expressed at
more than one temperature or in more than one strain.
Of the 61 proteins that were expressed in at least one
condition in this study, twelve were expressed in all six
conditions and twelve were expressed in only one condi-
tion. The highest number of proteins was expressed in
BL21-AI at 20°C, which included three proteins that
were not expressed at any other condition. One protein
that was not expressed in any other condition was
expressed in BL21-AI cells at 14°C and another six were
expressed only in BL21-AI cells at 30°C. More bands
that appeared to be degradation products were observed
for both expression strains at higher temperatures. With
strain BL21-AI, degradation products were observed for
6 proteins at 14°C, 8 at 20°C, 19 at 30°C and 17 at 37°C.
With strain C43 degradation products were observed for
4 proteins at 30°C and 11 at 37°C. In some cases the
level of expression of a single protein in different
conditions varied from not expressed to the highest
level of expression.
As the majority of the proteins that were expressed in
only one condition were expressed in BL21-AI at 30°C,
it would appear to be a good culture growth condition
to try first. However, since this condition also resulted
in the most proteins with degradation projects, it would
also be good to test strain C43(DE3), in which fewer
proteins were observed to have additional, lower mole-
cular weight bands that are likely to be degradation
products.
Correlations with Physical Features
Several physical characteristics of the proteins were pre-
dicted by sequence analysis and compared to the expres-
sion levels. Those factors that appeared to correlate with
expression were the number of TM helices (TMH), the
percentage of amino acids in TMH, and the grand aver-
age of hydropathicity.
Number of transmembrane helices
Transmembrane proteins with fewer TMH tended to be
expressed more often than those with a greater number
(Figure 3A). Those proteins that were not expressed had
on average more than 7 TMH, while those that were
expressed had on average fewer than 6 TMH (Chi-
square test p value = 0.005). However, some of the
higher molecular weight proteins were expressed, in
fact, proteins with has many as twelve TMH were
observed to have good levels of expression.
Percentage of amino acids in transmembrane helices
Expression levels were also compared for proteins with
different percentages of amino acids inside the transmem-
brane helices versus in periplasmic or cytoplasmic loops
and domains. Proteins that were not expressed tended to
have more of their amino acids in the TMHs than those
proteins that were expressed (Figure 3B, Chi-square test
for trend p value = 0.005).
Grand average of hydropathicity (GRAVY)
The GRAVY score [14] is a global descriptor of hydropa-
thy. It is the sum of hydrophobicity values for each of the
residues in the protein, normalized according to the pro-
tein length. More hydrophobic proteins have positive
GRAVY values, more hydrophilic proteins have negative
values. Proteins that were not expressed had a higher
average GRAVY score (Figure 3C, Chi-square test for
trend p value 0.008). This difference in average GRAVY
scores seems to stem from the lack of low GRAVY scores
in transmembrane proteins that were not expressed.
There were thirty-five expressed transmembrane proteins
with GRAVY scores below 0.70, while only seven trans-
membrane proteins that were not expressed had GRAVY
scores below 0.70. It would seem that a lower GRAVY
score is associated with a higher chance of successfully
Figure 2 Example of the Western blots used to estimate
relative expression levels. Proteins were expressed in strain BL21-
AI at 37°C. Whole cell extracts were subjected to SDS-PAGE and
transferred to membranes. The blots were probed with anti-6-His
antibodies. Overall, approximately 65% of the proteins were
expressed in at least one condition, and the sizes of most of the
expressed proteins were found to correspond approximately with
their predicted sizes. Lane 1 PA2628 (MW = 32 kDa), Lane 2 Control
6-His tagged protein (MW = 60 kDa), Lane 3 PA3773 (MW = 39
kDa), Lane 4 PA5291 (MW = 73 kDa), Lane 5 Molecular weight
markers with weights given in kDA, Lane 6 PA4083 (MW = 26 kDa),
Lane 7 PA4417 (MW = 51 kDa), Lane 8 PA5199 (MW = 49 kDa).
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expressing a transmembrane protein or with stability in
the membrane.
The correlation of expression with the number of
transmembrane helices, the percentage of amino acids in
transmembrane helices, and the GRAVY score does not
appear to be due to the method used to determine
expression level, PAGE gels and Western blots, because
in each of these cases, some of the proteins with more
TMH, more amino acids in the transmembrane helices,
and high GRAVY scores were found to be highly
expressed, which indicates that the method used to esti-
mate expression levels did not bias the results due to pro-
blems in electrophoresis or transfer to the blotting
membrane.
Among those traits which did not correlate with a sta-
tistically significant difference in transmembrane expres-
sion were the length of the N-terminus before the first
transmembrane helix, length of the C-terminus after the
last transmembrane helix, molecular weight of the pro-
tein, the number of rare codons (AUA, AGG, AGA,
CUA, CCC, CGG, and GGA), the number of amino acids
in cytoplasmic or periplasmic loops, or in the first loop
(between TM1 and TM2), or in the largest loop, the pre-
sence or absence of a signal peptide, or the length, hydro-
phobicity or amphiphilicty of a signal peptide.
In the study described above, the relative expression
levels of the transmembrane proteins were measured
under several culture growth conditions. The use of
E. coli strains, a T7 promoter, and a 6-His C-terminal
affinity tag resulted in the expression of 61 out of 87
test proteins (70%). During the time that the above
experiments were being performed, the results of several
other surveys of recombinant TM protein expression in
E. coli, Lactococcus lactis, or Saccharomyces cerevisiae
were published. In contrast to our work with proteins
from P. aeruginosa, most of the studies tested expres-
sion of TM proteins from E. coli or from a thermophile.
A few studies included TM transporters or other pro-
teins from pathogens. One study tested the recombinant
expression of yeast TM proteins in a yeast host strain.
Nordlund and coworkers studied the recombinant
expression of 49 E. coli transmembrane proteins with
eight or more transmembrane helices in E. coli [15].
They used several N-terminal affinity tags and a C-term-
inal 6-His tag. They also used multiple E. coli expression
hosts: BL21, C43, and C41. Overall, they reported 71%
of the target proteins were expressed, and they found
that protein expression worked best with low tempera-
tures and low IPTG concentrations. Hendersons and
coworkers studied the recombinant expression of trans-
porters and receptors from several pathogenic bacterial
species expressed with a C-terminal 6-His tag [16].
Figure 3 Summary of correlation of expression results with
physical features of the transmembrane proteins. For each
category of each characteristic, the numbers of proteins expressed
(grey bars) and not expressed (black bars) are indicated. A. Number
of transmembrane helices. Transmembrane proteins with fewer TMH
tended to be expressed more often than those with a greater
number of TMH. Those proteins that were not expressed had on
average more than 7 TMH, while those that were expressed had on
average fewer than 6 TMH (Chi-square test p value = 0.005). B.
Percentage of amino acids in transmembrane helices versus in
periplasmic or cytoplasmic loops and domains. Proteins that were
expressed tended to have fewer of their amino acids in the TMHs
than those proteins that were not expressed (Chi-square test for
trend p value = 0.005). C. Grand average of hydropathicity (GRAVY).
Proteins that were not expressed had a higher average GRAVY score
(Chi-square test for trend p value 0.008).
Madhavan et al. BMC Biotechnology 2010, 10:83
http://www.biomedcentral.com/1472-6750/10/83
Page 5 of 9
Optimization of expression conditions resulted in
expression of 34 out of the 40 proteins studied. The
Michel group studied the recombinant expression of 37
target proteins with at least 3 and usually 8 or more
TMH, including secondary transporters from Salmonella
and two hyperthermophiles [12]. They compared a vari-
ety of expression conditions including three different
vectors in E. coli and testing Lactococcus lactis as a sec-
ond expression host. Overall they observed that 78% of
the proteins were expressed in the E. coli host. When
they tested expression of a subset of the target protein
in Lactococcus lactis, only 40% of the subset were
expressed.
Several additional groups performed expression stu-
dies and looked for correlation between protein charac-
teristics and expression levels. As was observed for the
P. aeruginosa TM proteins, three groups observed that
recombinant expression of TM proteins correlated with
protein characteristics related to overall hydrophobicity
or the number of predicted transmembrane helices.
Dobrovsky and coworkers tested the expression of 280
proteins from E. coli and 77 from a thermophile, Ther-
motoga maritima [17]. Overall they found that there
was no advantage to using T. maritima proteins because
a slightly higher number of proteins from E. coli were
expressed. As in our study, they observed that the
majority of successfully expressed and purified TM pro-
teins had six or fewer transmembrane domains: 43% (54
out of 126) with 6 or fewer TMH were expressed, but
only 18% (28 out of 154) were expressed that had more
than six TMH. The Cross lab studied the expression of
99 transmembrane proteins from Mycobacterium tuber-
culosis in E. coli [18] and observed that 70% were
expressed. They observed expression of 64% of the pro-
teins with three or more TMH, but that number
increased to 78% of the proteins with only one or two
TMH. The Dumont lab studied the expression of 1092
eukaryotic membrane proteins, from S. cerevisiae, in a
S. cerevisiae host strain [19]. In that study about 50% of
the proteins that contain five or fewer TMH were
expressed at the highest levels, but fewer than 20% of
the proteins that contain seven or more THM were
expressed at high levels. They also compared the expres-
sion of proteins with respect to the amount of each pro-
tein predicted to be in the membrane. Over 50% of the
proteins predicted to have 20% or less of their amino
acids in TMH were highly expressed, but only 30% of
the proteins predicted to have more than 20% of their
amino acids in the TMH were highly expressed.
One group reported a lack of correlation between the
number of predicted TM helices and expression of TM
proteins. DeGier and coworkers [20] developed a novel
method for determining the level of expression of a
membrane protein in E. coli. They selected only proteins
that are predicted to have the C-terminus located in the
cytoplasm and expressed each protein as a C-terminal
GFP fusion protein. The resulting cytoplasmic GFP tag
was used to measure the amount of expression. This
method was later used as part of a larger scale study of
transmembrane protein topology [21]. In the latter
study, 397 TM proteins that were predicted to have a
cytoplasmic C-terminus were tested for expression as a
C-terminal GFP fusion protein in E. coli. In this study,
the authors note that they did not find a correlation
between protein expression and sequence characteristics
including codon usage, protein size, hydrophobicity, and
number of transmembrane helixes. It is not clear why
the correlations seen by other labs were not observed in
this study, although differences in the methods include
the use of only E. coli target proteins, the target proteins
only included proteins with C-terminus in the cyto-
plasm, the proteins were expressed as GFP fusion pro-
tein, and GFP fluorescence was used to measure
expression levels.
It is possible that the tendency for proteins with fewer
TMH to be more likely to be expressed might be due to
the method of biosynthesis of TM proteins. Perhaps
proteins with a larger number of transmembrane helices
are more likely to require more time for correct mem-
brane insertion folding. This greater time requirement
could lead to less protein produced. Also, proteins with
many TMH may tax the membrane insertion system,
leading to incorrect insertion or a higher propensity for
misfolding. If the translocation machinery required for
insertion of the protein into the lipid bilayer during
synthesis is limiting, perhaps fewer TM helices passing
through the machinery would allow more copies of the
protein to be made. If this model is correct, it could
result in a trend: better overexpression of proteins with
fewer TM helices than with more TM helices. Of
course, additional factors might help regulate expression
levels for individual proteins or specific types (kinases,
channels, etc.) by degradation, for example.
Conclusions
The variety of roles of transmembrane proteins in phy-
siological functions important to both medicine and
basic science make the determination of transmembrane
protein structures and mechanisms an important goal.
While quite feasible, as demonstrated by the presence of
almost two hundred structures of alpha-helical mem-
brane proteins in the PDB, problems in transmembrane
protein expression, solubilization, purification, and
structure determination have led many researchers
instead to focus on soluble proteins.
Surveys like this one could aid in overcoming the
technical bottlenecks in working with TM proteins and
could potentially aid in increasing the rate of structure
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determination. They can help identify those factors that
contribute to the technical problems so that they can be
specifically addressed in the future with novel methods.
In the mean time, identifying physical characteristics
that correlate with protein expression might aid in
selecting the “low hanging fruit of membrane proteins”,
or proteins that can be expressed to sufficient levels
using an E. coli expression system. For example, in this
study, the target proteins were from P. aeruginosa, a
gram negative bacterial opportunistic pathogen that
causes serious lung infections in people with cystic
fibrosis, and several TM proteins involved in infection
were found to be expressed at sufficient levels for
further study. The use of other expression strategies or
host species might be needed for increased levels of
expression of transmembrane proteins with other physi-
cal characteristics.
Specifically, the above study of P. aeruginosa TM pro-
teins and other reports indicated that a large percentage
of TM proteins can be expressed in E. coli, although
several labs observed that lower levels of expression
were observed for proteins with larger numbers of
TMH. It should also be noted that the expression levels
for the TM proteins in all of these studies, where noted,
were still far below those of soluble proteins, and vary-
ing vector, host strain or species, temperature, and other
expression conditions helped but did not vastly improve
expression. The next step in producing large amounts of
many transmembrane proteins for biochemical and
structural studies might require development of a novel
expression host that is specially tailored for TM protein
expression [22]. Our large collection of plasmid vectors
encoding TM proteins varying in molecular weight,
hydrophobicity, function, and other characteristics could
be used for these future studies.
Overcoming the technical problems in working with
TM proteins could potentially have a huge payoff by
increasing the rate of determining structures and
mechanisms of TM proteins, which make up 25% of all
proteins and are key to many physiological processes in
both health and disease.
Methods
Materials
Genomic DNA from Pseudomonas aeruginosa was
obtained from the ATCC (Manassas, VA). PCR primers
were synthesized by Integrated DNA Technology (Coral-
ville, Iowa). Pfu DNA polymerase, PCR reaction kits,
and PCR reaction buffers were purchased from Strata-
gene (La Jolla, CA). dNTP mixes and pENTR/SD/D-
TOPO cloning kits were purchased from Invitrogen Life
Technologies (Carlsbad, CA). PCR product purification
kits and DNA plasmid miniprep kits were purchased
from Qiagen (Valencia, California). Restriction enzymes
were purchased from MBI Fermentas (Hanover, MD).
Sequence Analysis and Selection of Target Proteins
The initial selection of target transmembrane proteins was
performed by identifying proteins predicted to have at
least two transmembrane helices as annotated in the PED-
ANT database [23,24] and also predicted by TMPRED
[25]. In addition, target proteins were selected so as to
include in the collection proteins that vary in physical fea-
tures such as molecular weight, number of predicted
transmembrane helices, overall hydropathy, etc. and pre-
dicted functions. The names and types of protein (enzyme,
transporter, etc.) were derived from the annotation of all
of the P. aeruginosa ORFs performed by the P. aeruginosa
Community Annotation Project [26,27]. TMPRED [25]
was utilized to predict the number and locations of trans-
membrane helices. Calculations of the GRAVY hydropathy
index were performed using the ProtParam tool of the
Expasy Proteomics server [28,29]. Calculations concerning
signal sequences were calculated by Signal P [30,31] and
Phobius [32].
Construction of TM Protein Gene Collection
The Gateway™ (Invitrogen) cloning technology system
was used for construction of the expression plasmids
encoding the transmembrane proteins of interest. The
genes encoding the target proteins were amplified by
PCR from genomic P. aeruginosa DNA (ATCC number
47085 D Pseudomonas aeruginosa PA01-LAC). PCR pri-
mers were designed with the computer program Clone
Manager (Scientific and Educational Software, Cary,
NC) using the following criteria: Each forward primer
contained a CACC sequence at the 5’ end. The CACC
sequences base pairs with the overhang sequence,
GTGG, in the pENTR/SD/D-TOPO vector (Invitrogen).
Each reverse primer was designed to remove the native
stop codon in the gene of interest for addition of a
C-terminal tag to the protein. Primer pairs were
designed so that they had similar melting temperatures
(between 50° C and 80° C) and were complimentary to
the template. The primers were synthesized by Inte-
grated DNA Technologies (Coralville, IA). PCR pro-
ducts that contained non-specific (unexpected) products
were purified using a gel purification kit (Qiagen) and
re-analyzed by agarose gel electrophoresis.
The TOPO® Cloning Reaction Kit (Invitrogen) was
used to insert each gene into the pENTR/SD/D-TOPO
vector to construct the “Entry Clone” plasmids. Cloning
reaction products were used to transform chemically
competent One Shot® TOP 10 E. coli cells (Invitrogen),
and miniprep DNA from transformants were digested
with restriction enzymes (MBI Fermentas) and analyzed
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by agarose gel electrophoresis to verify the presence of
the gene of interest. The high GC content of the P. aer-
uginosa DNA caused difficulty in the cloning steps,
making it difficult to obtain Entry clones of some of the
longer proteins. In order to increase the number of
clones for the expression studies, additional Entry Clone
plasmids were obtained from the Harvard Proteomics
Institute or from Open Biosystems (Huntsville, AL).
An Entry Clone plasmid with the correct insert for
each gene was then used to transfer the gene into pET-
DEST42 to construct the “Destination Clone” plasmids.
This vector features the T7 lac promoter for IPTG-indu-
cible expression of the target gene and adds a C-terminal
6-His tag to the target protein. Each LR recombination
reaction between an Entry clone and the pET-DEST42
Destination Vector was performed using Clonase Reac-
tion buffer (Invitrogen). The reactions were used for
transforming library efficiency DH5a cells (Invitrogen).
Restriction digests and gel electrophoresis of DNA mini-
preps (Qiagen) were used to check for the correct forma-
tion of PCR products and Entry and Destination clones.
To check for the absence of mutations in the cloned gene
sequences in the Destination Clone plasmids, DNA
sequencing was performed at the University of Chicago
DNA facility.
Expression Studies
Destination Vectors were used to transform E. coli
strain Bl21-AI (F-ompT hsdSB (rB-mB-) gal dcm araB::
T7RNAP-tetA) (Invitrogen) (with lon and ompT pro-
tease deficiencies (Invitrogen), which has the T7 RNA
polymerase under the control of the araBAD promoter
for inducible expression, and E. coli strain C43(DE3)
(which was derived fromBL21(DE3) [E. coli F-ompT
hsdSB (rB-mB-) gal dcm (DE3)]) [11]. For each expres-
sion experiment, overnight cultures (LB with 100 μg/ml
of ampicillin) were inoculated from fresh transformants
or frozen permanents and grown at 37°C with shaking
and used to inoculate fresh LB medium containing 100
μg/ml ampicillin (1:20 dilution of the initial culture) in
the morning. The cultures were then grown at 37°C
until they reached mid-log phase (OD600 = 0.4 - 0.6).
Expression of the target TM protein was induced with
the addition of L-arabinose to a final concentration of
0.2% w/v and IPTG to a final concentration of 1 M.
Incubation was continued for five hours after induction
for 30°C or 37°C cultures, or twenty-four hours for 14°C
or 20°C cultures. (Controls included cultures not treated
with arabinose and IPTG (uninduced), and those trans-
formed with vector alone.) 1 ml samples of the cultures
were taken and prepared for use in Western blots. The
samples were centrifuged, resuspended in 1× Laemmli
sample buffer containing 5% v/v b-mercaptoethanol,
vortexed thoroughly, boiled in a heat block at 90°C for 5
minutes, and subjected to SDS-PAGE. The presence of
the target protein was detected by rabbit anti-6-His tag
primary antibodies (cat# RDI-HISTAG1abr, Research
Diagnostics) with goat anti-rabbit-AP secondary anti-
body (GAR-AP control 91126 from BioRad). The Wes-
tern blots were scored visually, and bands migrating
near the predicted molecular weight were scored quali-
tatively. The scores were given as 0 = no expression, 1 =
minimal expression, 2 = medium expression, 3 = highest
level of expression. A purified control protein with a 6-
His tag was used for standardization from blot to blot.
The expression experiments were performed at 37°C,
30°C, 20°C, and 12°C for BL21-AI, and 37°C and 30°C
for CD43(DE3).
Additional material
Additional file 1: Table listing the 87 Pseudomonas aeruginosa
target proteins in the study, including the ORF numbers, gene
names, protein names, predicted number of transmembrane helices
and percent of amino acids in transmembrane helices, the
calculated GRAVY score, and the results of the expression studies
at several temperatures in two E. coli strains.
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